Husseini K Manji

Summary

Affiliation: Johnson and Johnson Pharmaceutical Research and Development
Country: USA

Publications

  1. pmc Bipolar disorder: from genes to behavior pathways
    Keri Martinowich
    Johnson and Johnson Pharmaceutical Research and Development, 1125 Trenton Harbourton Road, E32000, Titusville, New Jersey 08560, USA
    J Clin Invest 119:726-36. 2009
  2. pmc Acetylcholinesterase inhibition ameliorates deficits in motivational drive
    Keri Martinowich
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892 3711, USA
    Behav Brain Funct 8:15. 2012
  3. doi request reprint Impaired mitochondrial function in psychiatric disorders
    Husseini Manji
    Janssen Research and Development, LLC, Raritan, New Jersey 08869, USA
    Nat Rev Neurosci 13:293-307. 2012

Collaborators

Detail Information

Publications3

  1. pmc Bipolar disorder: from genes to behavior pathways
    Keri Martinowich
    Johnson and Johnson Pharmaceutical Research and Development, 1125 Trenton Harbourton Road, E32000, Titusville, New Jersey 08560, USA
    J Clin Invest 119:726-36. 2009
    ..We conclude with a synthesis of where the field stands and with suggestions and strategies for future areas of study to further increase our conceptual understanding of this complex illness...
  2. pmc Acetylcholinesterase inhibition ameliorates deficits in motivational drive
    Keri Martinowich
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892 3711, USA
    Behav Brain Funct 8:15. 2012
    ..This study evaluated a chronic restraint stress (CRS) protocol in modeling apathetic behavior, and determined whether administration of an anticholinesterase had utility in attenuating CRS-induced phenotypes...
  3. doi request reprint Impaired mitochondrial function in psychiatric disorders
    Husseini Manji
    Janssen Research and Development, LLC, Raritan, New Jersey 08869, USA
    Nat Rev Neurosci 13:293-307. 2012
    ..Enhancing mitochondrial function could represent an important avenue for the development of novel therapeutics and also presents an opportunity for a potentially more efficient drug-development process...